Although molecular studies in sporadic pancreatic cancer have identified somatic mutations in TP53 and SMAD4 in high frequency, our study as well as other germline pancreatic cancer predisposition studies outlined here show that the hereditary contribution of these genes is rare. Here, TP53 is linked to familial pancreatic carcinoma.